Schrier R W, Berl T
J Clin Invest. 1973 Feb;52(2):502-11. doi: 10.1172/JCI107207.
The present study was undertaken to investigate the mechanism whereby alpha adrenergic stimulation with intravenous norepinephrine results in a water diuresis. Renal perfusion pressure was kept constant in all experiments by adjustment of a suprarenal aortic clamp. In hydropenic anesthetized dogs the intravenous infusion of norepinephrine (0.5 mug/kg per min) was associated with a mean decrease in urinary osmolality from 616 to 126 mosmol/kg (P < 0.001) which increased to 532 mosmol/kg (P < 0.001) after the infusion was discontinued. During the same period of time the mean free water clearance increased from -0.437 to 1.59 (P < 0.001) and then returned to -0.314 ml/min (P < 0.001) after cessation of the infusion. This diuretic effect occurred in both innervated and denervated kidneys and was not associated with an increase in glomerular filtration rate or solute excretion. Systemic arterial pressure increased from 121 to 142 mm Hg during the norepinephrine infusion. Studies were also performed in hypophysectomized animals receiving a constant infusion of either 80 mug/kg per min or 20-40 muU/kg per min of vasopressin. In these animals, intravenous norepinephrine was not associated with changes in either urinary osmolality or free water clearance. The intrarenal administration of norepinephrine, in doses comparable with those reaching the kidneys during the intravenous studies, also resulted in no significant change in either urinary osmolality or free water clearance in hypophysectomized animals receiving 20-30 muU/kg per min of vasopressin. These results thus indicate that the water diuresis associated with intravenous norepinephrine is mediated primarily by suppression of vasopressin release rather than by changes in renal hemodynamics, renal innervation, or an effect of norepinephrine on the water permeability of the tubular epithelium.
本研究旨在探讨静脉注射去甲肾上腺素进行α肾上腺素能刺激导致水利尿的机制。在所有实验中,通过调节肾上腺上方的主动脉夹来保持肾灌注压恒定。在缺水麻醉的狗中,静脉输注去甲肾上腺素(0.5微克/千克每分钟)与尿渗透压平均从616降至126毫摩尔/千克(P<0.001)相关,输注停止后尿渗透压升高至532毫摩尔/千克(P<0.001)。在同一时间段内,平均自由水清除率从-0.437增加到1.59(P<0.001),输注停止后又恢复到-0.314毫升/分钟(P<0.001)。这种利尿作用在有神经支配和去神经支配的肾脏中均出现,且与肾小球滤过率或溶质排泄增加无关。去甲肾上腺素输注期间,全身动脉压从121毫米汞柱升至142毫米汞柱。还对接受每分钟80微克/千克或20 - 40微单位/千克血管升压素持续输注的垂体切除动物进行了研究。在这些动物中,静脉注射去甲肾上腺素与尿渗透压或自由水清除率的变化无关。在接受每分钟20 - 3,0微单位/千克血管升压素的垂体切除动物中,肾内注射与静脉研究中到达肾脏剂量相当的去甲肾上腺素,也未导致尿渗透压或自由水清除率发生显著变化。因此,这些结果表明,静脉注射去甲肾上腺素相关的水利尿主要是通过抑制血管升压素释放介导的,而非通过肾血流动力学变化、肾神经支配或去甲肾上腺素对肾小管上皮水通透性的影响。